DE602007005515D1 - Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon - Google Patents

Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon

Info

Publication number
DE602007005515D1
DE602007005515D1 DE602007005515T DE602007005515T DE602007005515D1 DE 602007005515 D1 DE602007005515 D1 DE 602007005515D1 DE 602007005515 T DE602007005515 T DE 602007005515T DE 602007005515 T DE602007005515 T DE 602007005515T DE 602007005515 D1 DE602007005515 D1 DE 602007005515D1
Authority
DE
Germany
Prior art keywords
short
polymorphic forms
term effect
salts
benzodiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007005515T
Other languages
German (de)
English (en)
Inventor
Gary Stuart Tilbrook
Louisa Jane Quegan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paion UK Ltd
Original Assignee
Paion UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion UK Ltd filed Critical Paion UK Ltd
Publication of DE602007005515D1 publication Critical patent/DE602007005515D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602007005515T 2006-07-10 2007-07-10 Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon Active DE602007005515D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0613693.1A GB0613693D0 (en) 2006-07-10 2006-07-10 Benzodiazepine salts (3)
PCT/GB2007/002583 WO2008007081A1 (en) 2006-07-10 2007-07-10 Short-acting benzodiazepine salts and their polymorphic forms

Publications (1)

Publication Number Publication Date
DE602007005515D1 true DE602007005515D1 (de) 2010-05-06

Family

ID=36926778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007005515T Active DE602007005515D1 (de) 2006-07-10 2007-07-10 Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon

Country Status (9)

Country Link
US (1) US8642588B2 (https=)
EP (1) EP2089378B1 (https=)
JP (1) JP5394238B2 (https=)
AT (1) ATE461927T1 (https=)
CA (1) CA2657369C (https=)
DE (1) DE602007005515D1 (https=)
ES (1) ES2343444T3 (https=)
GB (1) GB0613693D0 (https=)
WO (1) WO2008007081A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657347C (en) 2006-07-10 2014-11-18 Paion Uk Limited Short-acting benzodiazepine salts and their polymorphic forms
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP2450039A1 (en) * 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN102964349A (zh) * 2011-08-31 2013-03-13 江苏恒瑞医药股份有限公司 苯并二氮杂*衍生物的托西酸盐及其多晶型、它们的制备方法和用途
NZ702063A (en) * 2012-05-22 2016-11-25 Paion Uk Ltd Compositions comprising short-acting benzodiazepines
UA116452C2 (uk) 2012-08-31 2018-03-26 ПАЙОН ЮКей ЛІМІТЕД Режим дозування седативного засобу
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN103232454A (zh) * 2013-05-05 2013-08-07 王元青 治疗精神疾病的药物
CN104146970A (zh) * 2013-05-05 2014-11-19 王元青 治疗精神疾病的冻干粉针剂
CN103230595B (zh) * 2013-05-05 2014-10-08 李友香 治疗精神疾病的组合物
CN103202815B (zh) * 2013-05-05 2014-09-24 李友香 治疗精神疾病的注射剂
CN105130996B (zh) * 2015-08-07 2017-05-03 成都倍特药业有限公司 苯并二氮杂*衍生物的1,5‑萘二磺酸盐及晶型和它们的制备方法
EP3442539B1 (en) 2016-04-14 2025-04-09 Paion UK Limited Orally inhaled and nasal benzodiazepines
CN108503644B (zh) 2016-12-09 2019-06-14 成都倍特药业有限公司 一种苯并二氮杂*衍生物的氢溴酸盐及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933794A (en) 1971-08-04 1976-01-20 The Upjohn Company 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
US4724237A (en) 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
US5019583A (en) 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
AU678503B2 (en) 1993-09-24 1997-05-29 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
CA2143246C (en) 1994-03-16 2000-08-22 Thierry Godel Imidazodiazepines
US5834464A (en) 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
PT801651E (pt) 1995-01-06 2001-12-28 Hoffmann La Roche Hidroximetil-imidazodiazepinas e seus esteres
AU4382896A (en) 1995-02-02 1996-08-21 F. Hoffmann-La Roche Ag Acetylimidazobenzodiazepines
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
GB9911152D0 (en) * 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
CA2657347C (en) 2006-07-10 2014-11-18 Paion Uk Limited Short-acting benzodiazepine salts and their polymorphic forms

Also Published As

Publication number Publication date
EP2089378B1 (en) 2010-03-24
ES2343444T3 (es) 2010-07-30
US8642588B2 (en) 2014-02-04
US20100075955A1 (en) 2010-03-25
JP2009542787A (ja) 2009-12-03
JP5394238B2 (ja) 2014-01-22
WO2008007081A1 (en) 2008-01-17
CA2657369C (en) 2014-12-09
GB0613693D0 (en) 2006-08-16
CA2657369A1 (en) 2008-01-17
EP2089378A1 (en) 2009-08-19
ATE461927T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
DE602007009128D1 (de) Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
DE602007005515D1 (de) Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
ECSP088906A (es) PIRAZOLO 1,5-a PIRIMIDINAS
ME01532B (me) Jedinjenja
EA201070395A1 (ru) Ингибиторы polo-подобных киназ
ECSP109964A (es) Pirimidinas bicíclicas fusionadas
EA201001242A1 (ru) ПИРРОЛО[2,3-d]ПИРИДИНЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИНКИНАЗЫ
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
CR20110314A (es) Compuestos orgánicos
NI201200072A (es) Métodos y composiciones para tratar cáncer
CR20110620A (es) Derivados de n-(hetero)aril-pirrolidina de pirazo-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como ihnibidores de la quinasa janus
CL2013000077A1 (es) Uso de compuestos derivados de ribosas 1’ sustituidas que comprenden nucleobases de pirrolo[1,2-f][1,2,4]triazina para tratar infecciones por paramyxoviridae; compuestos derivados de ribosas 1’ sustituidas que comprenden nucleobases de pirrolo[1,2-f][1,2,4]triazina; y composicion farmaceutica que los comprende.
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
EA201071339A1 (ru) Фосфорсодержащие производные в качестве ингибиторов киназы
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
CL2011000729A1 (es) Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
EA201490912A1 (ru) Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
EA200802210A1 (ru) Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств
ECSP088925A (es) Nitrilos espirocíclicos como inhibidores de proteasa
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
MX2012005225A (es) Compuestos y composiciones de purina n-7 sustituida y pirazolopirimidina, y metodos de uso.
EA201170563A1 (ru) Метиленамины тиено[2,3-d]пиримидина и их применение в качестве антагонистов рецепторов a2a аденозина
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition